Cografting astrocytes improves cell therapeutic outcomes in a Parkinson’s disease model

Jae Jin Song, Sang Min Oh, Oh Chan Kwon, Noviana Wulansari, Hyun Seob Lee, Mi Yoon Chang, Eunsoo Lee, Woong Sun, Sang Eun Lee, Sunghoe Chang, Heeyoung An, Changjoon Lee, Sang Hun Lee

Research output: Contribution to journalArticle

11 Citations (Scopus)

Abstract

Transplantation of neural progenitor cells (NPCs) is a potential therapy for treating neurodegenerative disorders, but this approach has faced many challenges and limited success, primarily because of inhospitable host brain environments that interfere with enriched neuron engraftment and function. Astrocytes play neurotrophic roles in the developing and adult brain, making them potential candidates for helping with modification of hostile brain environments. In this study, we examined whether astrocytic function could be utilized to overcome the current limitations of cell-based therapies in a murine model of Parkinson’s disease (PD) that is characterized by dopamine (DA) neuron degeneration in the midbrain. We show here that cografting astrocytes, especially those derived from the midbrain, remarkably enhanced NPC-based cell therapeutic outcomes along with robust DA neuron engraftment in PD rats for at least 6 months after transplantation. We further show that engineering of donor astrocytes with Nurr1 and Foxa2, transcription factors that were recently reported to polarize harmful immunogenic glia into the neuroprotective form, further promoted the neurotrophic actions of grafted astrocytes in the cell therapeutic approach. Collectively, these findings suggest that cografting astrocytes could be a potential strategy for successful cell therapeutic outcomes in neurodegenerative disorders.

Original languageEnglish
Pages (from-to)463-482
Number of pages20
JournalJournal of Clinical Investigation
Volume128
Issue number1
DOIs
Publication statusPublished - 2018 Jan 2

Fingerprint

Astrocytes
Parkinson Disease
Dopaminergic Neurons
Mesencephalon
Neurodegenerative Diseases
Brain
Stem Cells
Transplantation
Therapeutics
Nerve Degeneration
Cell- and Tissue-Based Therapy
Neuroglia
Transcription Factors
Neurons

ASJC Scopus subject areas

  • Medicine(all)

Cite this

Song, J. J., Oh, S. M., Kwon, O. C., Wulansari, N., Lee, H. S., Chang, M. Y., ... Lee, S. H. (2018). Cografting astrocytes improves cell therapeutic outcomes in a Parkinson’s disease model. Journal of Clinical Investigation, 128(1), 463-482. https://doi.org/10.1172/JCI93924

Cografting astrocytes improves cell therapeutic outcomes in a Parkinson’s disease model. / Song, Jae Jin; Oh, Sang Min; Kwon, Oh Chan; Wulansari, Noviana; Lee, Hyun Seob; Chang, Mi Yoon; Lee, Eunsoo; Sun, Woong; Lee, Sang Eun; Chang, Sunghoe; An, Heeyoung; Lee, Changjoon; Lee, Sang Hun.

In: Journal of Clinical Investigation, Vol. 128, No. 1, 02.01.2018, p. 463-482.

Research output: Contribution to journalArticle

Song, JJ, Oh, SM, Kwon, OC, Wulansari, N, Lee, HS, Chang, MY, Lee, E, Sun, W, Lee, SE, Chang, S, An, H, Lee, C & Lee, SH 2018, 'Cografting astrocytes improves cell therapeutic outcomes in a Parkinson’s disease model', Journal of Clinical Investigation, vol. 128, no. 1, pp. 463-482. https://doi.org/10.1172/JCI93924
Song, Jae Jin ; Oh, Sang Min ; Kwon, Oh Chan ; Wulansari, Noviana ; Lee, Hyun Seob ; Chang, Mi Yoon ; Lee, Eunsoo ; Sun, Woong ; Lee, Sang Eun ; Chang, Sunghoe ; An, Heeyoung ; Lee, Changjoon ; Lee, Sang Hun. / Cografting astrocytes improves cell therapeutic outcomes in a Parkinson’s disease model. In: Journal of Clinical Investigation. 2018 ; Vol. 128, No. 1. pp. 463-482.
@article{4310e570402f444489ea11e5e1469712,
title = "Cografting astrocytes improves cell therapeutic outcomes in a Parkinson’s disease model",
abstract = "Transplantation of neural progenitor cells (NPCs) is a potential therapy for treating neurodegenerative disorders, but this approach has faced many challenges and limited success, primarily because of inhospitable host brain environments that interfere with enriched neuron engraftment and function. Astrocytes play neurotrophic roles in the developing and adult brain, making them potential candidates for helping with modification of hostile brain environments. In this study, we examined whether astrocytic function could be utilized to overcome the current limitations of cell-based therapies in a murine model of Parkinson’s disease (PD) that is characterized by dopamine (DA) neuron degeneration in the midbrain. We show here that cografting astrocytes, especially those derived from the midbrain, remarkably enhanced NPC-based cell therapeutic outcomes along with robust DA neuron engraftment in PD rats for at least 6 months after transplantation. We further show that engineering of donor astrocytes with Nurr1 and Foxa2, transcription factors that were recently reported to polarize harmful immunogenic glia into the neuroprotective form, further promoted the neurotrophic actions of grafted astrocytes in the cell therapeutic approach. Collectively, these findings suggest that cografting astrocytes could be a potential strategy for successful cell therapeutic outcomes in neurodegenerative disorders.",
author = "Song, {Jae Jin} and Oh, {Sang Min} and Kwon, {Oh Chan} and Noviana Wulansari and Lee, {Hyun Seob} and Chang, {Mi Yoon} and Eunsoo Lee and Woong Sun and Lee, {Sang Eun} and Sunghoe Chang and Heeyoung An and Changjoon Lee and Lee, {Sang Hun}",
year = "2018",
month = "1",
day = "2",
doi = "10.1172/JCI93924",
language = "English",
volume = "128",
pages = "463--482",
journal = "Journal of Clinical Investigation",
issn = "0021-9738",
publisher = "The American Society for Clinical Investigation",
number = "1",

}

TY - JOUR

T1 - Cografting astrocytes improves cell therapeutic outcomes in a Parkinson’s disease model

AU - Song, Jae Jin

AU - Oh, Sang Min

AU - Kwon, Oh Chan

AU - Wulansari, Noviana

AU - Lee, Hyun Seob

AU - Chang, Mi Yoon

AU - Lee, Eunsoo

AU - Sun, Woong

AU - Lee, Sang Eun

AU - Chang, Sunghoe

AU - An, Heeyoung

AU - Lee, Changjoon

AU - Lee, Sang Hun

PY - 2018/1/2

Y1 - 2018/1/2

N2 - Transplantation of neural progenitor cells (NPCs) is a potential therapy for treating neurodegenerative disorders, but this approach has faced many challenges and limited success, primarily because of inhospitable host brain environments that interfere with enriched neuron engraftment and function. Astrocytes play neurotrophic roles in the developing and adult brain, making them potential candidates for helping with modification of hostile brain environments. In this study, we examined whether astrocytic function could be utilized to overcome the current limitations of cell-based therapies in a murine model of Parkinson’s disease (PD) that is characterized by dopamine (DA) neuron degeneration in the midbrain. We show here that cografting astrocytes, especially those derived from the midbrain, remarkably enhanced NPC-based cell therapeutic outcomes along with robust DA neuron engraftment in PD rats for at least 6 months after transplantation. We further show that engineering of donor astrocytes with Nurr1 and Foxa2, transcription factors that were recently reported to polarize harmful immunogenic glia into the neuroprotective form, further promoted the neurotrophic actions of grafted astrocytes in the cell therapeutic approach. Collectively, these findings suggest that cografting astrocytes could be a potential strategy for successful cell therapeutic outcomes in neurodegenerative disorders.

AB - Transplantation of neural progenitor cells (NPCs) is a potential therapy for treating neurodegenerative disorders, but this approach has faced many challenges and limited success, primarily because of inhospitable host brain environments that interfere with enriched neuron engraftment and function. Astrocytes play neurotrophic roles in the developing and adult brain, making them potential candidates for helping with modification of hostile brain environments. In this study, we examined whether astrocytic function could be utilized to overcome the current limitations of cell-based therapies in a murine model of Parkinson’s disease (PD) that is characterized by dopamine (DA) neuron degeneration in the midbrain. We show here that cografting astrocytes, especially those derived from the midbrain, remarkably enhanced NPC-based cell therapeutic outcomes along with robust DA neuron engraftment in PD rats for at least 6 months after transplantation. We further show that engineering of donor astrocytes with Nurr1 and Foxa2, transcription factors that were recently reported to polarize harmful immunogenic glia into the neuroprotective form, further promoted the neurotrophic actions of grafted astrocytes in the cell therapeutic approach. Collectively, these findings suggest that cografting astrocytes could be a potential strategy for successful cell therapeutic outcomes in neurodegenerative disorders.

UR - http://www.scopus.com/inward/record.url?scp=85040183937&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85040183937&partnerID=8YFLogxK

U2 - 10.1172/JCI93924

DO - 10.1172/JCI93924

M3 - Article

C2 - 29227284

AN - SCOPUS:85040183937

VL - 128

SP - 463

EP - 482

JO - Journal of Clinical Investigation

JF - Journal of Clinical Investigation

SN - 0021-9738

IS - 1

ER -